Motif’s BCI technology is designed to monitor and regulate mental and cognitive states without a need for brain surgery.
Imperial researchers will receive almost £15m in funding to embark on cutting edge research to help overcome neurodegenerative disease.The four Imperial-led projects are among 18 projects funded by ...
A pioneering NHS trial is set to explore the potential of a brain-computer interface (BCI) that uses ultrasound to alter ...
Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and ...
Barking, Havering and Redbridge University Hospitals NHS Trust will trial a whole-brain computer interface to modulate ...
Motif Neurotech has received a multi-million dollar grant to support the development of a therapeutic brain-computer ...
The innovative tech, designed by US-based non-profit Forest Neurotech, would improve patients' moods by directly altering ...
Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and Invention Agency (ARIA) for multimillion dollar award to support Motif’s ...